Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
The Lancet. Haematology|October 6, 2023
Role of autologous haematopoietic cell transplantation in the treatment of systemic light chain amyloidosis in the era of anti-CD38 monoclonal antibodiesRajshekhar Chakraborty, Paolo Milani, Giovanni Palladini, et al.
The Lancet. Haematology|November 26, 2020
Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic reviewRajshekhar Chakraborty, Laura Cannella, Francesco Cottone, et al.
Annals of Hematology|April 17, 2024
Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelinesCharalampos Charalampous, Darshi Shah, Shaji Kumar, et al.
British Journal of Haematology|January 10, 2023
The promise and harms of screening for plasma cell dyscrasiasGhulam Rehman Mohyuddin, Rajshekhar Chakraborty, Edward R Scheffer Cliff
Annals of Hematology|May 9, 2020
Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trialsSomedeb Ball, Tapas Ranjan Behera, Faiz Anwer, et al.
Expert Review of Anticancer Therapy|July 22, 2015
Emerging therapeutic options for Waldenström macroglobulinemia/lymphoplasmacytic lymphomaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.
Transplantation and Cellular Therapy|April 30, 2021
Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid MalignanciesRajshekhar Chakraborty, Brian T Hill, Aneela Majeed, et al.
Expert Review of Hematology|July 4, 2015
Ibrutinib for the treatment of Waldenström macroglobulinemiaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.
Journal of Blood Medicine|April 8, 2015
A case of Hodgkin's lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVDRajshekhar Chakraborty, Shiva Kumar Reddy Mukkamalla, Garfield Gutzmore, et al.
Cancer|April 16, 2015
A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertaintiesRajshekhar Chakraborty, Bipin N Savani, Mark Litzow, et al.
Pageof 10